Sequencing

ASHG Honors Daniel MacArthur with Inaugural Early-Career Award

For Immediate Release Friday, July 14, 2017 12:00 p.m. U.S. Eastern Time Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org Geneticist to Receive Award at ASHG 2017 Annual Meeting BETHESDA, MD – The American Society of Human Genetics (ASHG) has named Daniel MacArthur, PhD, Assistant Professor in the Analytic and Translational Genetics Unit at... Read More

Parents of Children with Cancer Value Sequencing Results, Even if Non-actionable

Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org For Immediate Release Thursday, October 20, 2016 11:15 a.m. U.S. Pacific Time Findings Reported at ASHG 2016 Annual Meeting BETHESDA, MD – Parents of children newly diagnosed with cancer value the results of whole exome sequencing for a variety of reasons beyond clinical actionability, according to... Read More

ASHG 2016 Tipsheet: Neurogenetics

ASHG 2016 Tipsheet: Neurogenetics

Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org For Immediate Release Monday, October 3, 2016 12:00 pm U.S. Eastern Time (UTC-05:00) WHEN: Tuesday through Saturday, Oct. 18-22, 2016 WHERE: American Society of Human Genetics 2016 Annual Meeting Vancouver Convention Centre 999-1055 Canada Place, Vancouver, B.C. V6C 0C3 WHAT: Invited and platform (oral) sessions and... Read More

ASHG 2016 Tipsheet: Precision Medicine and Electronic Health Records

ASHG 2016 Tipsheet: Precision Medicine and Electronic Health Records

Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org For Immediate Release Monday, October 3, 2016 12:00 pm U.S. Eastern Time (UTC-05:00) WHEN: Tuesday through Saturday, Oct. 18-22, 2016 WHERE: American Society of Human Genetics 2016 Annual Meeting Vancouver Convention Centre 999-1055 Canada Place, Vancouver, B.C. V6C 0C3 WHAT: Invited and platform (oral) sessions and... Read More

NGS-based In Vitro Diagnostics

NGS-based In Vitro Diagnostics

In 2015 and 2016, ASHG submitted comments to the U.S. Food and Drug Administration (FDA) on two related proposed regulations for Next Generation Sequencing (NGS)-based in vitro diagnostics. Appreciative of being engaged in the process, ASHG submitted comments to further inform and clarify the issue. Related: Comments on “Use of Standards in FDA Regulatory Oversight... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy